Filing Details
- Accession Number:
- 0000904454-18-000631
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-10-02 18:58:24
- Reporting Period:
- 2018-09-24
- Accepted Time:
- 2018-10-02 18:58:24
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1526119 | Verastem Inc. | VSTM | Pharmaceutical Preparations (2834) | 273269467 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1563202 | Dan Paterson | C/O Verastem, Inc. 117 Kendrick Street, Suite 500 Needham MA 02494 | Chief Operating Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2018-09-28 | 3,000 | $7.00 | 23,286 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | Acquisiton | 2018-09-24 | 30,000 | $0.00 | 30,000 | $2.97 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
30,000 | 2018-09-24 | 2028-01-05 | No | 4 | A | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 54,446 | Indirect | By The Paterson 1996 Living Trust |
Footnotes
- The Reporting Person is the trustee of The Paterson 1996 Living Trust. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.
- On January 5, 2018, the Reporting Person was granted an option to purchase 75,000 shares of common stock. The option vests based on the Issuer's satisfaction of certain performance milestones by June 30, 2018, by March 31, 2019, and within the first twenty-four (24) months after the achievement of certain net sales targets. 20% of the performance criteria was met on April 6, 2018, resulting in vesting of the option as to 15,000 shares. 40% of the performance criteria was met on September 24, 2018, resulting in vesting of the option as to 30,000 shares.